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SUMMARY 
Deta1led descriptions of methods for measuring absolute levels and changes in 
plasma volume are presented along with derivations of pertinent equations. Reduc-
tion in variability of the Evans blue dye dilution technique using chromatographlc 
column pur1fication suggests that the day-to-day variability in the plasma volume in 
humans 1S less than ±20 mI. Mass density determination using the mechanical-
osc1llator technique provides a method for measuring vascular fluid shifts contin-
uously for assess1ng the density of the filtrate, and for quantifying movements of 
prote1n across microvascular walls. Equations for the calculation of volume and 
density of shifted fluid are presented. 
INTRODUCTION 
Determination of plasma volume (PV) w1th Evans blue dye (T-1824) llnked to 
album1n and measured spectrophotometrically was f1rst reported by Gregersen 
(ref. 1-3). Th1S techn1que was developed pr1marily for the Armed Forces. Essen-
t1ally the same techn1que, w1th some refinement on the separat10n and analys1s of 
the dye, is 1n use today. The accuracy and rel1ab1lity of this dye method depends 
upon the stab1lity of plasma album1n content over the perlod of measurement, as well 
as upon the k1netics of the bond between the dye and album1n molecule. Slmilar 
results are obtained when the Evans blue techn1que 1S compared with the radio-
10d1nated (1-131) labeled album1n technique (refs. 4-7). When the PV is determ1ned 
from analys1s of one 10-m1n post1njection dye sample, good agreement is obta1ned 
w1th the zero-t1me extrapolation techn1que, uS1ng multiple postinjection blood 
samples (ref. 6). Evans blue dye subjected to the Ames test for carc1nogen1c1ty 
(refs. 8 and 9) gave negat1ve results (ref. 10). 
W1th the advent of radioact1ve tracers, PV has usually been measured with one 
of the 10dine 1sotopes (1-125, 1-131). The problem then ar1ses of the appropr1ate-
ness of uS1ng even tracer quantities of radioisotopes in humans in nonl1fe-
threaten1ng situations. It 1S possible that "the r1sks of low levels of rad1ation 
are much greater than llnear extrapolations would 1nd1cate" (ref. 11). 
For these reasons we w1sh to reemphasize the usefulness of Evans blue dye for 
the measurement of PV and to present a technique Slightly modified from that of 
Campbell, Frohman, and Reeve (ref. 7) for analyzing the dye concentration. 
A second problem 1S the measurement of changes 1n PV over minutes and hours. 
Repeated dye 1njections result in saturation of the albumin-binding sites, creat1ng 
such h1gh pre1nfus1on plasma concentrations that injection of additional dye cannot 
be measured accurately. As a result, the short-term (hourly) changes in plasma 
volume have been calculated from sequential measurements of hematocrit (Hct) and 
hemoglobin (Hb) concentrations (refs. 12-14) and the Hct alone (refs. 15-17). In 
addition to the errors incurred in the measurement of Hct and Hb, and the probable 
error in using antecubital v.nou. blood values as representative of total blood 
volume levels, the act of drawine blood samples through a catheter may cause a 
change in vascular hemodynamics and change the Hct and Hb concentrations. In spite 
of these probable sources of error, use of the Hb-hct and Hct equations for calcu-
lating ohanges in PV have proven useful and will continue to be used. Derivations 
of these equations are presented. 
Recently, the development of instruments (ref. 18) for very accurate measure-
ment of blood and plasma density has made possible not only a fast and precise 
method for measuring ohanges In these volumes from discrete blood samples (refs. 19 
and 20), but it also provides for the first time a continuous measurement of changes 
in PV (refs. 21-23). This measurement technique is also described fully. 
EVANS BLUE DYE AND ISOTOPE LABELING 
Evans Blue Dye and 1-131 Labeled Albumin 
Gregersen and associates (ref. 2) were the first to use Evans blue dye (first 
obtained from Dr. H. M. Evans) to measure PV and, subsequently, they developed the 
method in detail (refs. 1 and 3). Measurement of dye diluted in untreated plasma 
results in rather large errors caused by lipemia or other Interfering substances 
which absorb at 615 nm. Allen and colleagues (refs. 24 and 25) were probably the 
first to use a detergent, which displaces the dye from albumin, and a cellulose pulp 
matrix to absorb the unbound dye. This basic technique was refined by Campbell 
et al. (ref. 26) and forms the basis for our technique, WhiCh is described here in 
detail. 
Reagents: 
1. Disodium hydrogen phosphate, Na2HP04 (anhydrous): 2~ solution 
(20 g/1000 ml). 
2. Teepol-phosphate [Teepol 610 ooncentrate, Particle Data Laboratories, Ltd., 
115 Hahn St., Elmhurst, IL 60126, (312) 832-5658]: Add 20 g Na2HP04 to 30 ml Teepol 
and make up to 1000 ml with distilled water. 
3. Potassium phosphate, monobaSIC, KH2P04 (anhydrous): B% solution (8 g/100 ml). 
4. 1:1 Acetone-water solution. 
5. Solka Floc BW-40 (60 ~) suspenSion of purified 
Corp., 650 Main St., Berlin, NH 03570, (603) 752-4600]: 
Solka Floc in 1000 ml 2% Na2HP04 (Reagent 1). 
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wood cellulose [James River 
Suspend approximately 10 g 
6. Evans blue dye (T-1824) standard [Harvey Laboratory and Pharmaceuticals, 
113 West Wyoming St., Philadelphia, PA 19140, (215) 451-1600]: Same lot number that 
1S used for injection. Refrigerate. (If in doubt about the lot number being the 
same, a quantity of dye will always be left over from the vial used for injection.) 
Preparat10n of columns: 
1. Prepare five columns for each subject: one for the standard, one for the 
blank uS1ng the "pre" sample, and three for the "post" samples. The columns can be 
fabricated by a glassblower; they are 25 cm long and have a burette stopcock on the 
lower end of a 13-cm glass tube with a 1-cm ins1de diameter; attached to the top of 
th1S tube 1S a larger glass tube 7 cm long with a 2.5-cm ins1de diameter. 
2. Insert approx1mately 100 mg (3 cm) of uncompressed glass wool 1nto each 
column, wash the tube with distilled water, and pack the glass wool firmly above the 
small constr1ct10n above the stopcock w1th a large stirring rod to a he1ght of about 
0.5 cm. 
3. With a pipette (upside down), pipette about 12 ml of the Solka Floc suspen-
Slon 1nto the column to a height of about 5 cm. (The p1petting should be carr led 
out qU1ckly after shak1ng the Solka Floc suspension, as 1t tends to settle very 
qU1ckly.) 
4. Wash each column using 
pack the column. (If poss1ble, 
that they w111 be packed well. 
reused.) 
a pipette w1th approx1mately 10 ml of 2% Na2HP04 to 
prepare the columns a day in advance of the test so 
When washed well with 2% Na2HP04' the columns can be 
Preparation of Evans blue for 1nject10n: 
1. After the dye has dra1ned to the bottom of the vial, w1pe the outs1de w1th 
alcohol and break open. Fill a ster11e, 10-ml syringe w1th the dye, using a ster1le 
1B-gauge needle. Remove the needle and expel all air from the barrel of the 
syr1nge. Push the level of the dye to the very tip of the syringe and attach a 
ster11e 20-gauge needle, bevel up. Replace cover over the needle, and label the 
syr1nge w1th the subject's name. W1pe away fingerpr1nts, and we1gh the syr1nge, 
needle, and cover on an analytical balance. Record th1S we1ght to four deC1mal 
places. 
2. Del1ver the loaded and we1ghed syr1nge to the person doing the 1nJection. 
Be sure the needle cover is returned w1th the empty syringe. 
3. Wipe f1ngerpr1nts from empty syr1nge and needle, and cover and rewe1gh the 
syringe apparatus. Subtract the empty we1ght (minus the weight of dye in needle) 
from the filled we1ght to determ1ne the exact weight of dye injected. 
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Preparation of the plasma samples: 
1. Centrifuge the heparinized blood from the "pre" injection and the "post" 
injection samples (3500 rpm for 10 min) and draw off and save the plasma in an 
appropriately labeled screw-cap vial. 
2. To 1 ml of the "pre" sample in a 50-ml Erlenmeyer flask, add 0.2 ml of the 
Evans blue standard solution (Reagent 6). Mix by swirling and let stand at least 
2 min. 
3. Set up the following in 50-ml Erlenmeyer flasks (one for each column): 
a. "Pre" injection plasma.--1 ml (BLANK) 
b. "Pre" injection plasma--1 ml + standard (STANDARD) 
c. "Post" injection plasma--1 ml (TEST) 
d. "Post" injection plasma--1 ml (TEST) 
e. "Post" injection plasma--1 ml (TEST) 
4. Add 15 ml of Teepol-phosphate to each flask, washing any plasma from the 
sides of the flask; swirl gently for about 15 sec and mix well. 
Extraction: 
1. Transfer the contents of each flask gently onto the Solka Floc in the 
column with a Pasteur pipette so that Its surface is not disturbed. 
2. RInse the flask with 5 ml of Teepol-phosphate and add this volume to the 
column. 
3. When the level of the solution has reached the Solka Floo, add at least 
10 ml of 2% Na2HP04 to the column. ThIS "wash" must be sufficient to remove all 
lnterfering substances, or else cloudiness will result in the final eluate. 
4. Allow the "wash" to pass through the column until the flUId is 0.5 cm above 
the Solka Floc. 
Elution: 
1. Elute Immediately. 
2. Pipette 0.5 ml of 8% KH2P04 into a 10-ml volumetric flask. This phosphate, 
with the Na2HP04 from the column, buffers the pH of the eluate to 7.0. 
3. Gently transfer approximately 5 ml of the acetone-water solution into the 
column and allow it to pass down until the blue front passes through the Solka Floc 
and nears the bottom. 
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4. Place the 10-ml volumetric flask with K2P04 under the column and allow the 
blue front to pass it. (Do not let the top of the column become dry; add more 
acetone-water if needed.) 
5. Allow the columns to stand 15 min before completing the elution. 
6. Add 4-5 ml of the acetone-water solut1on 1nto the column and cont1nue the 
elution unt11 the eluate fills the flask to the 10-ml mark; all the blue dye should 
have passed out of the plasma. 
7. Read the solutions in a spectrophotometer at 615 nm. 
Calculation: 
where 
v = 
D = 
St = 
v = 
T = 
1.03 = 
Plasma volume (ml) = 
volume (wt) of T-1824 1njected 
v x 0 x St x v 
T x 1.03 
d1lution of STANDARD (0.2 ml of 1:50; therefore d1lut1on = 1:250) 
absorbance of STANDARD 
volume of sample extracted (1 ml) 
absorbance of TEST sample m1nus absorbance of BLANK 
factor introduced to correct for slow dye uptake by the t1ssues 
Blood volume = PV x 100 100 - (0.87 Hct) 
(1) 
(2) 
where 0.87 1S a correction factor (about 4% of the Hct is trapped plasma; therefore, 
the true volume of packed cells 1S 0.96 Hct; whole-body Hct is 0.91 x true packed 
cell volume; hence, 0.96 x 0.91 = 0.87), and Hct is the raw Hct. 
Ames Test for Carc1nogen1c1ty of T-1824 
The Ames assay procedure (refs. 8,9) uS1ng Salmonella typh1murium (LT2) stra1ns 
TA1535, TA1537, TA1538, TA98, and TA100 is about 80% to 90% rel1able in detect1ng 
carc1nogens as mutagens. The test has about the same reliab1lity 1n 1dentifying 
chem1cals that are not carc1nogen1c. Therefore, neither a positive nor a negative 
response proves conclus1vely that a chem1cal 1S or 1S not carcinogenic to humans. 
The test consists of compar1ng the number of h1st1d1ne-1ndependent colonies on 
treated agar plates w1th the number found on control plates. Since all the plated 
Salmonella 1ndicator organ1sms undergo a few cell diV1s1ons in the presence of the 
test chem1cal, the assay procedure must be cons1dered sem1quant1tat1ve. The estab-
11shment of mutagen1c1ty (carcinogenlc1ty) rel1es on the demonstrat1on of a muta-
gen1c dose-response relationship. The test chem1cals are assayed at several dose 
levels w1th1n a nontox1c dose range. Toxic1ty is present 1f there 1S clearing of 
the background growth "lawn," a decrease In the number of "revertent" colonies below 
the spontaneous baCkground, or formation of pinpo1nt colonies of surv1v1ng cells. 
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The test chemicals are considered mutagenic in the Salmonella/microsome pre1ncuba-
tion assay if they elicit a reproducible dose-related increase in the number of 
histidine revertents per plate in one or more of the five test trains. The dye 
samples (General Diagnostics Lot 4018031 and Harvey Laboratories Lot 10810) were 
tested initially in strain TA9S up to 200 pI/plate, then in all five strains up to 
200 p/plate, and, finally, 1n all five strains up to a dose of 1000 pI/plate 
(approximately 4600 ~g of anhydrous dye). Each dose for human injection contains 
22.6 mg of dye that 1S diluted into 2.5 to 4.0 liters of plasma. Neither of the two 
Evans blue dye samples caused any tOX1C or mutagenic effects in any of the three 
assay tests. 
Errors in T-1824 Technique 
The repeatability of PV measurements with T-1824 depends upon the constancy of 
the plasma albumin content over the tracer equilibrium period, and from one measure-
ment per10d to the next. Results from our stud1es (refs. 6 and 13) have indicated 
that: (a) Both T-1824 space and 1-131 space, determ1ned from a single sample 
obta1ned 10 min after InjectIon, were comparable with the zero-time extrapolation 
values determined from ser1al sampling. (b) Four consecutive inject10ns of T-1824 
on alternate days, resultIng In residual dye bUIldup to 87% of one dose, d1d not 
SIgnIficantly affect the accuracy of measurement of Evans blue space. (c) Four 
consecutive injections of 1-131 on alternate days resulting in reSIdual radiation 
buildup of 85% of one dose, d1d not slgnificantly affect the accuracy of measurement 
of 1-131 space, and (d) T-1824 and 1-131 did not Interfere with each other when the 
two tracers were used simultaneously, and their results were comparable (refs. 6 
and 13). We have studIed the var1abllity of the basal PV (Evans blue space) in 
normal, healthy humans at varIOUS inte~vals up to 28 days (Table 1). The varia-
bility (±SE) between subjects ranges from 16 to 112 ml, whereas the constancy of the 
PV over 28 days ranges between -31 and +28 mI. The mean (±SE) of the absolute 
dlfferences between the seven palred measurements lS 8 ±7 mI. These f1ndings empha-
Slze the constancy of the day-to-day PV in men and women llvlng their normal lives 
(Table 1). 
There are two additional problems wlth the albumin-labeled tracer methods. One 
lnvolves the constancy of the albumin content over the per10d of measurement. The 
net exchange of album1n can vary from 4 to 7% within a 60-min period wlth subjects 
at rest or undergoing mild exerCIse (refs. 27), and there can be an addlt10nal Sh1ft 
of albumin (-4% to -8%) durlng 10 min of maximal exercise (refs. 15,27,28). A 
comparIson was made between the percent change ln PV, determined from control and 
postmaximal-exercise Evans blue spaces, and the change in PV from the Hb-Hct equa-
tlon. The postexerc1se Evans blue value was the concentration of res1dual dye 
remaining after the single preexerclse injection. There was essentially no positive 
relationship between the PV determ1ned from the two methods, which suggests that 
analysis of residual dye 1S useless as an estimate of PV immediately after heavy 
exerClse (ref. 29) and after 8 hr of water immerSIon (ref. 30). The second problem 
is that the use of these tracer techn1ques is limited when one must make repeated 
measurements of PV over short time intervals. Since the minimum equilibratlon tlme 
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for these tracers is 10 min, PV determ1nations at shorter intervals are d1fficult to 
perform accurately. It is doubtful whether determinations made at consecutive 
10-m1n 1ntervals would be accurate because of the progressively increasing tracer 
concentrat1ons in the succeeding pre1njection basel1ne samples. Clearly, another 
analytical techn1que for est1mating changes 1n PV at shorter intervals is needed. 
HemoglobIn-HematocrIt and Hematocrit Transformat1ons 
It is interest1ng that the early methods for estimat1ng PV and total blood 
volumes 1nvolved the measurement of Hb concentrat1on before and after the 1nject1on 
of hemoblobin Solut1ons (ref. 31). The relat1ve constancy of the number of red 
blood cells and their content of Hb prov1des the baS1S for two related alternat1ve 
methods for calculat1ng changes 1n PV over short-term 1ntervals (hours). They 
1nvolve the measurement of the Hb concentrat1on and Hct (the ratio of the packed 
cell volume to the cell volume plus PV), and measurement of the Hct alone. 
The first equat10n for the calculat10n of changes in PV uS1ng the Hb and Hct 
was publ1shed by Elk1nton, Danowski, and Winkler (ref. 12): 
rewr1tten as 
PV 
a 
(1 - Hkt2) 
= x (1 Hkt 1) 
(1 - Hct ) 
a 
x (1 - Hctb) 
Strauss et al. (49) put 1t 1n the form of percent change: 
(1 - Hct2) 
x x 100 (1 - Hct 1) 
rewr1tten as 
% 6PV = 100 
(1 - Hct
a
) 
x (1 Hctb) 
where a = after fluid Sh1ft and b = before fluid Sh1ft. 
(3) 
(4) 
(5) 
(6) 
If the right-hand side of equat10n (6) is subtracted from 100, the percent 
change In PV 1S obta1ned directly. The derivation of the equat10n 1S presented in 
Table 2. In this equat10n the change in PV 1S calculated from the Hct, assum1ng the 
red cell volume and the Fcell rat10 (total body Hct/large vessel Hct) rema1n 
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constant and the total blood volume is equal to the sum of the cell volume and the 
PV. Use of the Hb concentration corrects for changes in red cell water content, 
i.e., the mean corpuscular volume. 
If the red cell volume and the Fcell 
Hct are a measure of the changes in PV. An 
in PV from Hct values alone is given by "an 
a proportionality factor [100/(100 - Hctb)] 
before (b) and after (a) ratios: 
% PV 100 = x 100 - Hctb 
ratio remain constant, changes in the 
equation for calculating percent change 
Beaumont et ale (ref. 16). It involves 
and tue percent difference between the 
100(Hctb - Hcta ) 
Hct
a 
(8) 
There have been numerous reports in which percent changes 1n Hct, calculated 
with only the percent difference factor, were equated with percent changes 1n PV 
(refs. 32-38). The results 1ndicated that the percent changes 1n Hct were always 
smaller than the percent changes 1n PV. Some explanat10ns for this d1screpancy 
between the two calculated values were a different1al rate of change between them 
(ref. 3), or some unexpla1ned problem with the slte of blood sampl1ng (ref. 35). 
Another explanation 1S that percent changes 1n plasma are calculated on the baS1S of 
the PV alone, wh1le percent changes 1n Hct are calculated on the baS1S of total 
blood volume, not just the plasma port1on (ref. 11). Use of the proport10nal1ty 
factor 1n equat10n (1) (Table 2) converts (l.e., reduces) the base from total blood 
volume to the PV, so now all compar1sons are made on the bas1s of the PV. ThUS, any 
variable measured on the baS1S of total blood volume (e.g., Hb) can be converted to 
a PV basis w1th the Hct proportionality factor, prov1ded the the Fcell rat10 1S 
known. 
If PV is measured and red cell volume 1S assumed to be constant, a posttreat-
ment PV can be calculated (ref. 11), PYa = BVa - CVb , where BV 1S the blood 
volume, and CV 1S the red cell volume, and 
PV = a 
-2 [PVb/1 - (Hctb x 10 )] - PVb 
Hct x 10-2 
a 
10- 2 ) - PVb - (Hctb x 
(9) 
Also, 1f the percent change in PV 1S calculated in the convent1onal manner, 
i.e., % ~PV = [(PVb - PVa)/PVb] x 100, the percent change in any plasma const1tuent 
concentration (e.g., protein) must be calculated w1th the "after" value 1n the 
denom1nator (ref. 11): 
( 10) 
The correlation coefficient between measured PV and PV calculated from the Hct 
changes with data from five stud1es from the literature 1S better than 0.95 
(ref. 17). Finally, the percent change in the total content (Co) of a plasma con-
stituent can also be calculated from the before-and-after Hct values and the 
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concentrat1ons (Cn) of the constituent being measured (ref. 28). The compos1te 
equation is as follows (ref. 29): 
% ~Co = ( 11) 
The major advantage of the Hct transformation is that it requires determ1nat1on 
of only the Hct. The deficIencies are that 1t assumes a constant red blood cell 
volume or mean corpuscular volume (MCV) and that the venous Hct 1S representative of 
the total body Hct. A correction factor of 0.91 is usually appl1ed in resting 
subjects to correct venous Hct to total body Hct (refs. 3 and 13), but changes 1n 
th1S factor would introduce errors 1n the calculated volumes (ref. 39). One way to 
prov1de some correction for potent1al changes in the mean corpuscular volume 1S to 
comb1ne measurements of Hct w1th those of red cell hemoglob1n. The Hb/Hct 1S a 
measure of the mean corpuscular hemoglobin concentration (MCHbCn) (ref. 40) and can 
be used to est1mate changes 1n the mean corpuscular volume (Hct/red blood cell (RBC) 
concentrat1on) when the RBC concentrat1on 1S not available (ref. 41). A stable 
MCHbCn would also 1nd1cate an unchanged MCV because a change 1n cell volume, result-
1ng from a shift of fluid 1nto the RBC, would change the RBC mass; the Hb concentra-
t10n would rema1n unchanged, wh1le the Hct and MCHbCn would change. 
Compar1son of Hct and Hb-Hct Methods for Calculat1ng Percent Change 1n PV 
There 1S not total agreement among stud1es for the calculated changes 1n PV 
w1th the Hct versus the Hb-Hct methods under some exerC1se and environmental cond1-
t1ons. On the bas1s of results obta1ned from stud1es on men undergoing exerC1se 
dehydrat1on, thermal dehydration, and submax1mal and max1mal exerC1se 1n a thermo-
neutral env1ronment, Cost111 et al. (refs. 42 and 43) concluded that the changes 1n 
PV calculated with the Hct method w1II be 1n error unless correct1ons are made for 
changes 1n the mean corpuscular volume. The1r data suggest that the MCV 1S reduced 
under these conditions because of 1ncreases 1n plasma osmolality. On the other 
hand, Van Beaumont and Rochelle (ref. 44) found no change 1n MCV with 1ncreases 1n 
plasma osmolallty of 12%, lnduced by maxlmal arm exerClse. It seems clear that 
short-term 1ntenS1ve stress has essent1ally no effect on MCV as measured by the 
regress10n of percent change In PV calculated with the Hct or the Hb-Hct. It 1S 
poss1ble that 1ncreased osmot1c concentrat1ons decrease the MCV 1n V1VO, but th1S 
hypothes1s has not been conf1rmed (ref. 45). Perhaps there 1S an upper homeostat1c 
Ilm1t, 1n V1VO, for 1ncreased osmolal1ty beyond WhlCh the MCV is unchanged. But a 
11near relationsh1p is unl1kely, because the integr1ty of the RBC volume would 
presumably be protected w1thln some well-def1ned "normal" range of plasma osmot1c 
var1ab1lity. The positive SIde of this normal range appears to be 0 to 13 mosmol/kg 
(ref. 13), and the Hct equation could be used to estimate changes in PV. W1th1n 
th1S osmot1c range fall values from studies 1nvolv1ng maximal exercise short-term 
(max1mal) +Gz acceleration, 10° tllting, SItting 1n a hot env1ronment, and 
submaxlmal exerC1se below 50% ~02 max for less than 60 mln. The probable effect of 
longer-durat1on stress (greater than 1 hr) on changes 1n MCV suggest factors other 
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than just an increase in plasma osmolality are involved, because osmotic equillbrium 
between plasma and RBe probably occurs within minutes, not hours. 
While the Hct and Hb-Hct transformations provide a method for estimating 
changes in PV at much shorter intervals than with Evans blue dye or lodine isotope 
dllution, they cannot be used to measure changes in PV continuously. Measurement of 
changes in blood density on-line can be ~sed to estimate changes in plasma or blood 
volumes continuously. This method wlil be discu&~ed in the followlng sectlon. 
BLOOD DENSITOMETRt 
Densitometry on Biologic Fluids 
Blood denslty (BO) measurements were first performed in 1881 with the fall Ing-
drop method (ref. 46). In the late 1940s, slmilar technlques were used to estimate 
Hct, Hb, and plasma proteln concentrations (refs. 41 and 48). But because all early 
density technlques (refractometry, faillng-drop method) were elther Impreclse or 
laborious, densltometry had been abandoned for use in physiological research. For 
physical and industrial research purposes, the reliable mass and volume measure-
ments, often hard to perform with the required accuracy, remained the method of 
chOlce for determlnatlons of a sample's mass density, l.e., mass per unlt volume. 
In 1966 a new method was introduced--the mechanical osclilator technique 
(MOT)--which was first used for high-precision measurements on homogenous flulds and 
gases in conjunctlon wlth X-ray refractlon analysis of molecular structure 
(ref. 18). Shortly thereafter, the MOT was used to measure the denslty of bever-
ages, gasoline, tritiated water, inorganiC and organlc solutions, etc. Recently, 
ItS use for contlnuous measurement on blood (refs. 21-23,49-51) and lymph (ref. 52) 
was introduced. 
The MOT combines the advantages of hlgh accuracy (up to 10-6 g/ml); small 
volumes (~50 ~l); appllcabillty for contlnuous recordings; short measurlng tlme 
(~1 s per measuring cycle in the contlnuous mode, dependlng upon the dimenSlons of 
the osc1llator used); and independence from an external acceleratlon fleld, which 
allows its use in welghtless condlt1ons. With the Introduction of th1S method In 
biology, physiology, and clin1cal med1clne, h1gh-prec1sion denslty measurements of 
blood and its constItuents have rega1ned their usefulness for biomedical research. 
How the Mechanlcal Osc1llator Techn1que Works 
Mass density determinations with the denslty-measuring apparatus (OMA) employ 
the MOT, which 1S based on the mass-sprlng principle: the actual resonant frequency 
(f) of an oscillating U-shaped glass tube, comparable to a tunlng fork In shape and 
phYSIcal features, is determined accordlng to 
f = 1/2 ~/c/(M + O·V) 
o 
10 
(12) 
where c lS the constant of elasticity for the glass tube, Mo is the inertial mass 
of the empty tube (the oscillator), D is the density (mass per un1t volume), and 
V the volume of the sample contained in the tube. 
The tube lS brought to bend lng-type osclilatlons perpendicular to the plane of 
the U by a variable electromagnetic sinuso1dal field, and the movements of ltS tlP 
are sensed by an optical system. The resonant frequency is tracked by a feedback 
loop. The osclilation duration is determined precisely for each measurlng perlod by 
sensing and averaging several hundred slngle cycles on-line. The length of the 
measurlng period can be preset (e.g., =1, 2, 4, or 8 sec ln the case of low-volume 
DMAs). The MOT lS based on high-resolution oscillation time determlnatlons. 
Before startlng a set of density recordings, the system is callbrated wlth two 
medla of known denslty, usually alr and water. Then, density values are computed by 
the bUllt-ln microprocessor from the average oscillation time. The denslty slgnal 
can be dlrectly fed to a dlgltal/analog output for continuous recordlngs. Thus, 
hlgh-preclsion density measurements can be made on small volumes of blOloglC flulds 
wlthout mass or volume measurements. 
The vlbratlon of the DMA's glass tube creates centrifugal forces, the resultant 
of WhlCh 1S directed toward the tlP of the oscillator. Since thlS force lS «1 gram 
1n the normal operating range (ref. 53), no lnterference in terms of blood sedimen-
tatlon occurs during BD measurements, particularly in the cont1nuous mode. 
Deposltlon of plasma protelns and corpuscular elements (e.g., thrombocyte 
aggregates) can be prevented by coatlng the glass surface wlth slilcon prlor to 
measurement uSlng Surfasll™ (Plerce Co.). No difference between contlnuously 
determlned BD and values from synchronously obtalned blood samples could be observed 
when coated osc1llators were used, especially for operation exceedlng several hours 
(ref. 21). 
Slgnlflcance of the Mass Denslty of B10log1C Fluids 
The denslty of lsotonlC flulds at a given temperature is a llnear function of 
the fluld's total proteln concentratlon (refs. 54 and 55); for blood thlS lS 
approXlmately 
BPC = PPC(1 - HctR - HctW) + MCHbCn . HctR + MLPC . HctW ( 13) 
where BPC lS the blood proteln concentratlon, PPC is the plasma proteln concentra-
tIon, MCHbCn lS the mean corpuscular hemoglobln concentrat10n, MLPC lS the mean 
leukocyte proteln concentration, HctR lS the red cell hematocrlt, and HctW 1S the 
whlte cell hematocrit (given as volume fract10n). The contrlbutlon of blood plate-
lets 1S lncorporated lnto the plasma protein concentratlon after mlld centr1fugatlon 
(platelet-rlch plasma), and into the mean leukocyte proteln concentratlon after 
lntense centrifugation of blood. If hemolysls occurs, the influence of additlonal 
Hb on the plasma density can be compensated for by colorimetrlc means (ref. 56) to 
determme the "true" plasma denslty. 
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The plasma protein and mean corpuscular hemoglobin concentrations are regulated 
within narrow limits under normal physiological conditions whereas Hct may vary more 
wIdely; Hctw is usually low «0.01). Since the mean corpuscular Hb concentration IS 
four to five times greater (300-400 gram/liter) than the plasma protein concentra-
tion (60-80 gil), blood protein and Hct are closely correlated. Consequently, the 
BD WhICh is a function of the blood proteIn concentration, is correlated lInearly 
with Hct (refs. 19,20,54). However, PD--~t a given temperature and proteIn concen-
tration--is influenced by plasma lipid, glucose, and urea concentratIon (ref. 55). 
Further, the leukocyte density becomes more Important in cases of leukocytosis. 
These confoundIng factors may diminIsh the accuracy ~: densItometry for the determI-
nation of protein concentratIon and Hct, although It remains effectIve for rough 
estimatIons, particularly on a screenIng basIs. 
In a single experIment, In which the amount of these potentially confounding 
factors can be assumed to remaIn constant, densIty alteratIons are a precise measure 
of plasma proteIn and Hb concentratIon shifts. Moreover, the densIty of fluId 
shifted between the extravascular and Intravascular compartments can be computed, 
SInce this "fIltrate" densIty differs from both blood and plasma densItIes (refs. 21 
and 39). ExperIments WhICh combine this technique WIth the advantage of contInuous 
BD measurements reveal new Insight not only Into the amount but also Into the time-
course of rapid mIcrovascular fluId exchange (refs. 21,23,50,51). Dur1ng contInuous 
densItometry, proper compensatIon of possIble thermal deviatIons becomes most Impor-
tant. Recent studies (refs. 19 and 57) have provided data for correct1ons of tem-
perature-induced errors In on-line density recordIngs. 
DensIty Shifts WIth Changes In Posture 
Blood volume regulat10n In humans IS serIously challenged by assuming an 
uprIght posture. QUIet standIng leads to rapid and persistent hemoconcentration, 
whIch may result in PV losses in excess of 20%. Calculation of the densIty of flUId 
leavIng or enterIng the cIrculatory system, under IsotonIC conditIons, allows for 
the assessment of the amount of proteIn WhICh moves across the cap1llary walls 
durIng orthostat1cally Induced capIllary filtratIon. 
The mass densIty of red cells does not change WIth alterations of posture 1n 
euhydrated man (ref. 58). ThIS observation helps to valIdate the calculatIon of the 
density and volume of flUId shIfted between 1ntra- and extravascular compartments, 
USIng formulae WhICh assume no net fluid transfer between the corpuscular and plasma 
compartments. For both Inward fIltratIon (from assumpt10n of the supIne poslt1on 
after the upright) and outward movement of flUId (uprIght POSItIon after supIne), 
essentially the same fluid denslty (1008 gram/liter, 37°C) IS found wlth an 
unchanged Fcell ratIO. This result lndicates a proteln concentration of ~30 gil 
In the shifted fluid, or approxImately 40% of that in the blood plasma (39). 
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Continuous Blood Density Measurements 
The MOT has been employed for continuous measurements on arterial blood in 
animals (refs. 21,23,50) and during blood dialysis in patients (refs. 23 and 49). 
Recently, coronary sinus blood in dogs was used for on-line densit~ recordings 
(ref. 51). The accuracy of the density data was better than 1·10- g/ml in these 
stud1es. 
Changes in the plasma protein concentration after blood volume alteratIons 
provide an accurate measure of volume replacement only if the net protein concentra-
tion of the shifted flu1d is known. Results from different hemorrhage studies are 
contradictory and demonstrate that filtrate protein content ranges from zero to 
about half of the plasma concentration after hemorrhage. If a slgn1ficant amount of 
prote1n moves with the filtrate, then the degree of fluid replacement 1S under-
estimated from calculations which are based on the assumption that the observed 
plasma prote1n concentration changes are due to an admixture of prote1n-free 
fluid. Continuous monitoring of the mass density of flow1ng blood, combined w1th 
plasma dens1ty and Hct determinat1ons, can help to elucidate the volume and prote1n 
concentration of even small flu1d shifts. Results from a recent study on the 
effects of moderate hemorrhage (ref. 21) suggested that e1ther the 1nward-shlfted 
flu1d had a h1gher density than normal ultrafiltrate, and/or there was a rise of the 
rat10 of whole-body to large-vessel Hct (Fcell ratio). 
The investigation of rapid compensatory mechanisms after blood loss 1S compli-
cated by the poss1bility of simultaneous shifts in the Fcell rat10. If It IS 
altered, the observed changes in measured Hct are due only in part to transcapillary 
fluid flux, and volume shift results from the Hct data may be 1n error. 
If the Fcell ratio is constant, as dur1ng pass1ve body t1ltlng, the denSIty 
of transcap1llary exchanged fluid can be calculated from blood denSIty (BD) and 
plasma dens1ty (PO) changes (refs. 21 and 39) uS1ng the formulae: 
Hct'(1 - HctO) 
FD = PdO - Hct
o 
_ Hct' (PDO - PO') (14) 
or 
FD = BD - Hct' (BD B ') o Hcto - Hct' 0 - 0 
(15) 
where PDO' HctO' and BOO refer to the state wIth the larger blood volume (after 
volume repletion, or before outward shift), whereas PO', Hct', and BD' refer to 
the hemoconcentrated condit1on. Hct 1S corrected for whole body hematocrIt. 
Provided there are no measur1ng errors and the red cell volume rema1ned constant, 
the flu1d density (FD) from both equations should be identical. 
Whereas plasma density and Hct cannot be measured continuously, the mechanical 
oscillator techn1que provides the advantage of precise on-line measurement of blood 
density changes. As an example, figure 1 shows the first blood density curve 
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measured in a human which was obtained from venous (cubital) blood when the subject 
changed from the sitting to the standing and the supine positions. There are tran-
sient deviations from a simple exponential time-course curve immediately after the 
postural changes which may be caused by baroreflex-driven dynamic resettings of the 
peripheral reSistance, thus influencing the capillary filtration pressure on a 
minute-by-m1nute basls, 1n addltlpn to the normal hydrostatic effects on mIcrovascu-
lar fluid exchange. 
From the magnitude of the density alterations, the volume of the exchanged 
fluid (FV) can be calculated from 
BOO - BO' 
FV ; ~~---",.,,-BO' - FO (fraction of BVO) (16) 
Thus, WIth use of blood densitometry, not only the magnitude, but also the 
continuous time-course of flUId ShIfts can be detected. Use of this technIque 
should result In sIgnificant advances in our knowledge of fluId-electrolyte-proteln 
physiology. 
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TABLE 1, Variability (X tSE) of Evans blue space (plasma volume) in 
normal males (m, 18-32 yr) and females (f, 30-41 yr) in the basal 
state in 3- tQ 21-day periods, [A] ~ XD - XD aYn aY1 
SubJ. Day 1 Day 4 Pay 8 Day 14 Day 24 Day 28 
12 (m) 3531 3556 [ ... 25] 
±BO ±19 
17 (JII) 3489 3461 [-28) 
±76 ±Bl 
19 (m) 3112 3115 [+3] 
t120 ±105 
7 (m) 3453 3459 [+6] 3422 [ -311 
±160 ±157 ±172 
23 (m) 2971 2989 [+18] 
±97 ±90 
1 (f) 2678 2683 [+5] 
±98 ±91 
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TABLE 2. Derlvatlon of the hemoglobin-hematocrit equation for calcula-
tion of change In plasma volume 
BaSlc equations: where: PV = plasma volume 
ev = corpuscular volume (i) PV = BV - ev BV = (total) blood volume 
Hct = hematocrit, whole (i1) ev = BV x Hct body (red + whlte) 
Hb = blood hemoglobin 
concentration 
a = after fluid Shlft 
b = before fluld ShIft 
. Hbb (Ill) BVa = BVb x Hb 
a 
(assumlng unchanged 
Fcell ratIO) 
PV
a 
- PVb llPV = -;;.;.......--PVb 
(fraction of PVb) 
(eq. i) llPV = 
(BVa - eVa) - (BVb - evb ) 
BVb - eVb 
BV - (BV x Hct
a
) - [BVb - (BVb x Hctb )] (eq. il) llPV a a = BVb - (BVb x Hctb ) 
BV (1 - Hct
a
) - BVb(l - Hctb ) llPV a = BVb(l - Hctb ) 
( eq . 111) llPV 
BVb x (Hbb/Hba )( 1 - Hcta ) - BVb(l - Hctb ) 
= BVb(l Hct ) c 
(Hbb/Hb
a
)( 1 - Hct ) - (1 - Hct ) Hbb - Hct a b 
= 
a llPV 
- Hctb 
= Hb
a 
x 
- Hctb 
% hPV • 100 [::: • ~ ~ ::~:]- 100 (Eq. 7) 
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FIgure 1.- Continuous blood density recordIng In a man sItting, standing, 
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sity: 999.5 gil at 37°C). The flow rate was 1.5 mllmln, and the 
sample volume In the oscIllator was 0.1 mI. 
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